Small Cap Biotech
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Trend Stats
1-Month Return
-3.65%
3-Month Return
-1.77%
12-Month Return
+38.56%
Volatility Score
2.9
RSI
45.0
ST Trend
Down
LT Trend
Up
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Small Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | $505B | +29.04% | +11.86% | +8.42% | 2.3 | Up | Up |
| AMGN | Amgen | $237B | +54.73% | +18.93% | +8.17% | 2.4 | Up | Up |
| GILD | Gilead Sciences | $193B | +32.21% | +19.91% | +3.09% | 2.4 | Up | Up |
| VRTX | Vertex Pharma | $133B | +24.33% | +10.75% | +1.47% | 2.4 | Neutral | Up |
| REGN | Regeneron Pharma | $83B | +40.00% | +23.63% | +0.40% | 2.8 | Neutral | Up |
| MRNA | MODERNA | $80B | +648.32% | +250.93% | +9.88% | 10.3 | Up | Up |
| NTRA | Natera | $58B | +109.83% | +52.61% | +3.37% | 4.3 | Up | Up |
| RVMD | REVOLUTION MEDIC | $40B | +243.23% | -0.93% | -1.97% | 5.0 | Down | Up |
| BIIB | Biogen | $37B | +67.25% | +24.96% | +10.18% | 2.7 | Up | Up |
| ALNY | Alnylam Pharma | $30B | -51.66% | -16.64% | -9.12% | 3.9 | Down | Down |
| ROIV | ROIVANT SCIENCES | $26B | +100.27% | +3.96% | -0.90% | 3.7 | Down | Up |
| UTHR | United Therapeut | $25B | +40.36% | +10.95% | +20.04% | 3.9 | Up | Up |
| INCY | Incyte | $23B | +26.76% | -0.84% | -7.16% | 2.8 | Down | Up |
| INSM | Insmed | $20B | -41.51% | -13.05% | -21.08% | 4.4 | Down | Down |
| EXEL | Exelixis | $16B | +66.66% | +15.96% | +13.75% | 2.5 | Up | Up |
| NBIX | Neurocrine Biosc | $15B | -0.90% | -18.06% | +2.30% | 2.6 | Down | Down |
| HALO | Halozyme Therape | $14B | +89.92% | +55.41% | +11.73% | 2.6 | Up | Up |
| BBIO | BRIDGEBIO PHARMA | $13B | +26.35% | -17.33% | +4.34% | 3.1 | Down | Down |
| SMMT | SUMMIT THERAP | $12B | -19.76% | +3.27% | -5.96% | 6.8 | Down | Down |
| BMRN | Biomarin Pharm | $11B | +2.70% | -4.96% | -10.06% | 2.9 | Down | Down |
| MDGL | Madrigal Pharmct | $10B | +3.02% | -20.08% | -15.36% | 3.9 | Down | Down |
| PCVX | VAXCYTE | $9.5B | +43.10% | +8.61% | +6.97% | 8.2 | Down | Up |
| TWST | TWIST BIOSCIENCE | $9.3B | +310.20% | +51.36% | -11.72% | 10.9 | Down | Up |
| KRYS | KRYSTAL BIOTECH | $9.2B | +67.36% | -4.89% | -8.85% | 3.3 | Down | Neutral |
| KYMR | KYMERA THERAP | $9.2B | +89.14% | +0.34% | -4.08% | 4.6 | Down | Up |
| PTGX | Protagonist Ther | $9B | +84.92% | +2.22% | -0.19% | 4.0 | Down | Up |
| IBRX | IMMUNITYBIO | $8.7B | +232.79% | +11.08% | -4.75% | 9.2 | Down | Up |
| CYTK | Cytokinetics | $8.5B | +5.88% | -25.26% | -6.96% | 3.4 | Down | Down |
| SYRE | Spyre Therap | $8.4B | +286.52% | -9.66% | +2.45% | 5.8 | Down | Up |
| TGTX | TG Therap | $8.3B | +62.50% | -2.40% | -3.27% | 3.9 | Down | Up |
| ARWR | Arrowhead Phrmct | $8.2B | +52.68% | -33.14% | -13.35% | 3.9 | Down | Down |
| ALKS | Alkermes | $7.3B | +46.41% | -17.63% | +3.56% | 3.2 | Down | Up |
| IONS | Ionis Pharmaceut | $7.1B | -39.42% | -23.16% | -2.28% | 3.7 | Down | Down |
| PRAX | PRAXIS PRECIS | $7.1B | +45.40% | -21.54% | -10.34% | 5.2 | Down | Down |
| IOVA | IOVANCE BTHRPTCS | $6.4B | +526.22% | +174.66% | +38.27% | 7.3 | Up | Up |
| RYTM | RHYTHM PHARM | $6.1B | -19.19% | -13.04% | -9.13% | 3.8 | Down | Down |
| GRAL | GRAIL | $5.9B | +48.28% | +88.39% | +22.14% | 8.3 | Up | Up |
| IMVT | IMMUNOVANT | $5.9B | +50.00% | -27.84% | -17.75% | 4.3 | Down | Down |
| KOD | KODIAK SCIENCES | $5.5B | +368.86% | +113.63% | +178.01% | 11.3 | Up | Up |
| CGON | CG ONCOLOGY | $5.5B | +41.31% | -13.23% | -15.88% | 4.5 | Down | Down |
| 0 | 0 | 0 | 0 | Bullish | Bullish |